Monoclonal antibodies - Approaching adolescence in diagnostic immunoassays

As monoclonal antibodies enter their second decade, they continue to exhibit great potential for the diagnostic immunoassay industry. This is reflected in the current and future products which exploit their characteristics. However, much like a young child approaching adolescence, they are not without their share of peculiarities and growing pains. An awareness of the inherent advantages and disadvantages of the monoclonal antibodies themselves and the new technologies associated with them will continue to make their outlook bright for diagnostic and other applications.